Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Morellco Pharma A/S
A/S
Dissolved
CVR 40651055
Vesterballevej 5
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK 271K
EBITDA margin
3.5%
Equity ratio
63.2%
Financial strength
Net profit 2020
DKK 2K
1 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2020
Key figures
Annual report 2020
Revenue
DKK 271K
—
EBITDA
DKK 9K
—
Net profit
DKK 2K
—
Total assets
DKK 636K
—
Equity
DKK 402K
—
Employees
1
—
Company information
Legal name
Morellco Pharma A/S
CVR number
40651055
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juli 2019
Share capital
DKK 400.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af 1 direktør
Contact
Address
Vesterballevej 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Fredericia
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
Income statement
DKK thousands
Item
2020
Revenue
271
Staff expenses
-261
EBITDA
9
Depreciation & amort.
-0
EBIT
9
Net financials
-3
Profit before tax
6
Tax
4
Net profit
2
Balance sheet
DKK thousands
Item
2020
Total assets
636
Equity
402
Long-term debt
0
Short-term debt
234
Total debt
234
Financial ratios
5-year trend
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
2020
2020
Equity ratio
63.2%
This company
38.2%
Market median
+65% vs market
2020
2020
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
2020
2020
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
2020
2020
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
2020
2020
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
2020
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2019-07-10 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JM
John Morell Frellsen
Chief Executive Officer
Chief Executive Officer
2019
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CW
Christoffer Winther Frellsen
Board of Directors
2019
—
—
MW
Marcus Winther Frellsen
Chairman
2019
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
MORELLCO HOLDING ApS
Company
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Morellco Pharma A/S also hold positions in
0
other companies.
Person
Role here
Other companies
John Morell Frellsen
Chief Executive Officer
0 companies
Christoffer Winther Frellsen
Board of Directors
0 companies
Marcus Winther Frellsen
Chairman
0 companies